Medical Condition News

RSS

Precision Antibody to develop antibodies for NCI's Clinical Proteomic Technologies for Cancer

Precision Antibody(TM) has been selected as the antibody developer for a component of the National Cancer Institute (NCI)'s Clinical Proteomic Technologies for Cancer (CPTC), which is focused on improving the number and standardizing the quality of monoclonal antibody reagents available for clinical cancer proteomics research.

28 Oct 2009

Orexigen Therapeutics presents phase 3 trial results of Contrave for treating obesity

Orexigen® Therapeutics, Inc. today announced results from new intent to treat (ITT) analyses from the COR-I and COR-II Phase 3 trials of Contrave® (naltrexone SR/bupropion SR), the first of two late stage Orexigen candidates for the treatment of obesity. These data expand on top-line results announced in July and complement findings from a panel discussion on Saturday where the Company presented data on Contrave patients who completed 56 weeks of therapy.

28 Oct 2009

NBPF develops 'Safe 'til Stable' preventative care program for bipolar disorder patients

A major breakthrough in mental health has been developed, a cooperative venture between the National Bipolar Foundation and the MedicAlert Foundation; a preventative care program called "Safe 'til Stable." It provides vital medical information to emergency responders in time of need through our live 24-hour emergency response service.

28 Oct 2009

Upsher-Smith Laboratories publishes data on Slo-Niacin and Lipitor combination study

Results of the SLIM Study ("Slo-Niacin® and Atorvastatin Treatment of Lipoproteins and Inflammatory Markers in Combined Hyperlipidemia") were recently published in the Journal of Clinical Lipidology.

28 Oct 2009

Susceptibility to schizophrenia and autism may have common genetic fingerprints, says researchers

Johns Hopkins scientists report having used a commercially available drug to successfully "rescue" animal brain cells that they had intentionally damaged by manipulating a newly discovered gene that links susceptibility genes for schizophrenia and autism.

28 Oct 2009

Arena Pharmaceuticals presents data from its Phase 3 trial of LOrcaserin

Arena Pharmaceuticals, Inc. reported today data from the pivotal BLOSSOM (Behavioral modification and LOrcaserin Second Study for Obesity Management) Phase 3 trial that demonstrate improvements in patients' body composition, cardiovascular risk factors and quality of life. These findings add to the previously announced top-line BLOSSOM data that showed highly significant weight loss with lorcaserin over one year of treatment in 4,008 patients.

28 Oct 2009

U.S. PTO awards Endocyte patent for vitamin receptor binding anti-cancer agents

Officials at Endocyte Inc., a cancer drug discovery and development company, announced Tuesday (Oct. 27, 2009) that the company has been awarded a patent from the U.S. Patent and Trademark Office covering vitamin receptor binding anti-cancer agents.

28 Oct 2009

Dementia patients face higher risk of flu mortality; refine guidelines needed for testing and vaccination policies

An epidemiological study on pneumonia and influenza (P&I) in adults age 65 and over reports that patients with dementia are diagnosed with flu less frequently, have shorter hospital stays, and have a fifty percent higher rate of death than those without dementia.

28 Oct 2009

Contour Products promotes the results of a 2009 survey conducted among respiratory therapists

In conjunction with National Respiratory Care Week, Contour Products(TM), a leader in the sleep support and comfort industry, is proud to promote the results of a 2009 survey conducted among respiratory therapists who work with CPAP patients daily. One of the most common issues among CPAP therapy users is discomfort when sleeping with their CPAP mask, as a result of the mask pressing against their face.

28 Oct 2009

Culture-based treatment may be effective for reducing depression

A genetic tendency to depression is much less likely to be realized in a culture centered on collectivistic rather than individualistic values, according to a new Northwestern University study.

28 Oct 2009

Dr. Jay Smith receives PASSOR Legacy Award and Lectureship from AAPM&R

The American Academy of Physical Medicine and Rehabilitation (AAPM&R) awarded Jay Smith, M.D., of Mayo Clinic's Department of Physical Medicine and Rehabilitation, the Physiatric Association of Spine, Sports and Occupational Rehabilitation (PASSOR) Legacy Award and Lectureship.

28 Oct 2009

National Institutes of Health awards $735,000 grant for prenatal obesity and diabetes research

The National Institutes of Health has awarded Clemson University professor Maria Mayorga and Medical University of South Carolina professor Kelly Hunt a $735,000 grant to study the effects of a mother's obesity and diabetes on infant health in certain ethnic groups.

28 Oct 2009

First nationwide Prostate Cancer registry for identifying effective treatment options

RemedyMD (www.RemedyMD.com), the leading provider of Patient registry software, today announced the first nationwide Prostate Cancer registry to help clinicians and researchers identify which interventions are most appropriate for specific patient populations.

28 Oct 2009

Bcl-2 inhibitor may enhance chemotherapy treatment in patients with prostate cancer

In trying to better predict a patient's response to chemotherapy for cancer treatment, a team of investigators at The Cancer Institute of New Jersey (CINJ) and Rutgers, The State University of New Jersey, has identified a way to better manipulate a gene product to cause cancer cells to die.

28 Oct 2009

MMRF raises over $1.8 million at its 13th annual Fall Gala

The Multiple Myeloma Research Foundation (MMRF) raised over $1.8 million at its 13th annual Fall Gala held on Saturday evening in Greenwich, Conn. Funds raised at this premier fundraising event, attended by more than 1,000 guests, will support the MMRF’s efforts to accelerate the development of the next generation of treatments for patients with multiple myeloma, a rare and incurable blood cancer, and to find a cure for the disease.

28 Oct 2009

Pediatric and adolescent patients who receive antipsychotic medications experience weight gain

Many pediatric and adolescent patients who received second-generation antipsychotic medications experienced significant weight gain, along with varied adverse effects on cholesterol and triglyceride levels and other metabolic measures, according to a study in the October 28 issue of JAMA.

28 Oct 2009

DiabetEZE, an energy bar designed and developed for diabetics launched

Innova Nutrition announced today the launch of "DiabetEZE," an energy bar designed and developed for diabetics, but great for everyone.

28 Oct 2009

Multidisciplinary center to be launched for treatment of advanced liver disease

Distinguished transplant and cancer surgeon, Alan Hemming, MD, has been recruited to the University of California, School of Medicine to launch a multidisciplinary center for the treatment of advanced liver disease at the UC San Diego Medical Center and Moores UCSD Cancer Center.

28 Oct 2009

Vegetable intake during pregnancy can protect unborn child against diabetes

New evidence is emerging for how important it is for pregnant women to eat good, nutritious food. Expecting mothers who eat vegetables every day seem to have children who are less likely to develop type 1 diabetes, is revealed in a new study from the Sahlgrenska Academy at the University of Gothenburg, Sweden.

28 Oct 2009

Barrett's esophagus patients are at no greater risk of dying from esophageal cancer

New Mayo Clinic research has found that survival rates of patients with Barrett's esophagus, which can be a precursor for esophageal cancer, are no different than the survival rates for the general population. These findings were presented today at the 2009 American College of Gastroenterology (ACG) Annual Meeting in San Diego.

28 Oct 2009

Medical Condition News

Precision Antibody to develop antibodies for NCI's Clinical Proteomic Technologies for Cancer

Orexigen Therapeutics presents phase 3 trial results of Contrave for treating obesity

NBPF develops 'Safe 'til Stable' preventative care program for bipolar disorder patients

Upsher-Smith Laboratories publishes data on Slo-Niacin and Lipitor combination study

Susceptibility to schizophrenia and autism may have common genetic fingerprints, says researchers

Arena Pharmaceuticals presents data from its Phase 3 trial of LOrcaserin

U.S. PTO awards Endocyte patent for vitamin receptor binding anti-cancer agents

Dementia patients face higher risk of flu mortality; refine guidelines needed for testing and vaccination policies

Contour Products promotes the results of a 2009 survey conducted among respiratory therapists

Culture-based treatment may be effective for reducing depression

Dr. Jay Smith receives PASSOR Legacy Award and Lectureship from AAPM&R

National Institutes of Health awards $735,000 grant for prenatal obesity and diabetes research

First nationwide Prostate Cancer registry for identifying effective treatment options

Bcl-2 inhibitor may enhance chemotherapy treatment in patients with prostate cancer

MMRF raises over $1.8 million at its 13th annual Fall Gala

Pediatric and adolescent patients who receive antipsychotic medications experience weight gain

DiabetEZE, an energy bar designed and developed for diabetics launched

Multidisciplinary center to be launched for treatment of advanced liver disease

Vegetable intake during pregnancy can protect unborn child against diabetes

Barrett's esophagus patients are at no greater risk of dying from esophageal cancer

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News